The Association of Controlling Nutritional Status (CONUT) Score with Survival in Patients with Surgically Treated Renal Cell Carcinoma and Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387(10021):894–906. doi:10.1016/S0140-6736(15)00046-X
   PubMed Web of Science ®Google Scholar
• Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Gruenvald V, Horwich A, ESMO Guidelines Committee. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(Suppl. 5):v58–v68. doi:10.1093/annonc/mdw328
   PubMed Web of Science ®Google Scholar
• Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73(1):111–122. doi:10.1016/j.eururo.2017.07.036
   PubMed Web of Science ®Google Scholar
• Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, Shariat SF, Wood CG, Zigeuner R. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62(1):100–114. doi:10.1016/j.eururo.2012.02.030
   PubMed Web of Science ®Google Scholar
• Kuroda D, Sawayama H, Kurashige J, Iwatsuki M, Eto T, Tokunaga R, Kitano Y, Yamamura K, Ouchi M, Nakamura K, et al. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer. 2018;21(2):204–212. doi:10.1007/s10120-017-0744-3
   PubMed Web of Science ®Google Scholar
• Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions, v.5.1. Cochrane Collaboration Web site 2011. http://www.cochrane-handbook.org. (updated March 2011).
   Google Scholar
• Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K. Preoperative controlling nutritional status (CONUT) score as novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy. Urol Oncol. 2017; Sep35(9):539.e9–539.e16. doi:10.1016/j.urolonc.2017.04.012
   PubMed Web of Science ®Google Scholar
• Kang HW, Seo SP, Kim WT, Yun SJ, Lee SC, Kim WJ, Hwang EC, Kang SH, Hong SH, Chung J, KORCC (KOrean Renal Cell Carcinoma) Group, et al. Prognostic impact of nutritional status assessed by the Controlling Nutritional Status (CONUT) score in patients with surgically treated renal cell Carcinoma. Nutr Cancer. 2018;70(6):886–894. doi:10.1080/01635581.2018.1490448
   PubMed Web of Science ®Google Scholar
• Zheng Y, Bao L, Wang W, Wang Q, Pan Y, Gao X. Prognostic impact of the Controlling Nutritional Status score following curative nephrectomy for patients with renal cell carcinoma. Medicine (Baltimore). 2018;97(49):e13409. doi:10.1097/MD.0000000000013409
   PubMed Web of Science ®Google Scholar
• Xu H, Tan P, Jin X, Ai J, Lin T, Lei H, Yang L, Wei Q. Validation of the preoperative controlling nutritional status score as an independent predictor in large Chinese cohort of patients with upper tract urothelial carcinoma. Cancer Med. 2018;7(12):6112–6123. doi:10.1002/cam4.1902
   PubMed Web of Science ®Google Scholar
• Elghiaty A, Kim J, Jang WS, Park JS, Heo JE, Rha KH, Choi YD, Ham WS. Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging. J Cancer Res Clin Oncol. 2019;145(4):957–965. doi:10.1007/s00432-019-02846-x
   PubMed Web of Science ®Google Scholar
• Song H, Xu B, Luo C, Zhang Z, Ma B, Jin J, Zhang Q. The prognostic value of preoperative controlling nutritional status score in non-metastatic renal cell carcinoma treated with surgery: A retrospective single-institution study. CMAR. 2019;11:7567–7575. doi:10.2147/CMAR.S209418
   Web of Science ®Google Scholar
• Bao Z, Li Y, Guan B, Xiong G, Zhang L, Tang Q, Wang T, Li X, Fang D, Zhou L. High preoperative controlling nutritional status score predicts a poor prognosis in patients with localized upper tract urothelial cancer: A propensity score matching study in a large Chinese center. CMAR. 2020;12:323–335. doi:10.2147/CMAR.S225711
   Web of Science ®Google Scholar
• Iseki Y, Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, Ikeya T, Muguruma K, Tanaka H, Toyokawa T, et al. Impact of the Preoperative Controlling Nutritional Status (CONUT) score on the survival after curative surgery for colorectal cancer. PloS One. 2015;10(7):e0132488. doi:10.1371/journal.pone.0132488
   PubMed Web of Science ®Google Scholar
• Toyokawa T, Kubo N, Tamura T, Sakurai K, Amano R, Tanaka H, Muguruma K, Yashiro M, Hirakawa K, Ohira M. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. BMC Cancer. 2016;16:722–731. doi:10.1186/s12885-016-2696-0
   PubMed Web of Science ®Google Scholar
• Takagi K, Yagi T, Umeda Y, Shinoura S, Yoshida R, Nobuoka D, Kuise T, Araki H, Fujiwara T. Preoperative Controlling Nutritional Status (CONUT) score for assessment of prognosis following hepatectomy for hepatocellular carcinoma. World J Surg. 2017;41(9):2353–2360. doi:10.1007/s00268-017-3985-8
   PubMed Web of Science ®Google Scholar
• Shoji F, Haratake N, Akamine T, Takamori S, Katsura M, Takada K, Toyokawa G, Okamoto T, Maehara Y. The preoperative controlling nutritional status score predicts survival after curative surgery in patients with pathological stage I non-small cell lung cancer. AR. 2017;37(2):741–747. doi:10.21873/anticanres.11372
   Web of Science ®Google Scholar
• Kwon W-A, Kim S, Kim SH, Joung JY, Seo HK, Lee KH, Chung J. Pretreatment prognostic nutritional index is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with targeted therapy. Clin Genitourinary Cancer. 2017;15(1):100–111. doi:10.1016/j.clgc.2016.07.025
   PubMed Web of Science ®Google Scholar
• Tanriverdi O. A discussion of serum albumin level in advanced-stage hepatocellular carcinoma: a medical oncologist’s perspective. MedOncol Northwood Lond Engl. 2014;31:1–5.
   Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Resnik N, Repnik U, Kreft ME, Sepčić K, Maček P, Turk B, Veranič P. Highly selective anti-cancer activity of cholesterol-interacting agents methyl-β-cyclodextrin and ostreolysin A/pleurotolysin b protein complex on urothelial cancer cells. PLoS One. 2015;10(9):e0137878. doi:10.1371/journal.pone.0137878
   PubMed Web of Science ®Google Scholar
• Xu J, Dang Y, Ren YR, Liu JO. Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc Natl Acad Sci U S A. 2010;107(10):4764–4769. doi:10.1073/pnas.0910872107
   PubMed Web of Science ®Google Scholar
• Resnik N, Sepcic K, Plemenitas A, Windoffer R, Leube R, Veranic P. Desmosome assembly and cell-cell adhesion are membrane raft-dependent processes. J Biol Chem. 2011;286(2):1499–1507. doi:10.1074/jbc.M110.189464
   PubMed Web of Science ®Google Scholar